De novo mTOR inhibitor-based immunosuppression in ABO-incompatible kidney transplantation

Clinical Transplantation
Martina KochBjoern Nashan

Abstract

ABO-incompatible (ABOi) kidney transplantation (KTx) has become an accepted therapeutic option in renal replacement therapy for patients without a blood group-compatible living donor. Using different desensitization strategies, most centers apply B-cell depletion with rituximab and maintenance immunosuppression (IS) with tacrolimus and mycophenolic acid. This high load of total IS leads to an increased rate of surgical complications and virus infections in ABOi patients. Our aim was to establish ABOi KTx using an immunosuppressive regimen, which is effective in preventing acute rejection without increasing the risk for viral infections. Therefore, we selected a de novo immunosuppressive protocol with low-dose calcineurin inhibitor and the mTOR inhibitor everolimus for our ABOi program. Here, we report the first 25 patients with a complete three-yr follow-up treated with this regimen. Three-yr patient survival and graft survival were 96% and 83%. The rate of acute T-cell-mediated rejections was low (12%). Cytomegalovirus (CMV) infection was evident in one patient only (4%). Surgical complications were common (40%), but mild in 80% of cases. We demonstrate that ABOi KTx with a de novo mTOR inhibitor-based regimen is feasible with...Continue Reading

References

Jan 24, 2002·Therapeutic Drug Monitoring·Björn Nashan
Mar 5, 2003·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·Michael RobsonDavid Goldsmith
Jun 16, 2004·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·Kota TakahashiUNKNOWN Japanese ABO-Incompatible Kidney Transplantation Committee
Sep 16, 2005·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·Stefan VítkoUNKNOWN RAD B201 Study Group
Sep 12, 2006·Transplant International : Official Journal of the European Society for Organ Transplantation·Claudio Ponticelli, Giovanni Banfi
Jan 26, 2007·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·H IshidaK Tanabe
Sep 19, 2007·Clinical Journal of the American Society of Nephrology : CJASN·Daniel L Bohl, Daniel C Brennan
Nov 29, 2007·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Jörg BeimlerMartin Zeier
Nov 29, 2007·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Adrian EgliHans H Hirsch
Jan 25, 2008·Transplantation·Kazunari Tanabe
May 24, 2008·Transplantation·Catherine BonvoisinJean-Marie Krzesinski
Aug 30, 2008·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Tobias OettlMichael Dickenmann
Dec 17, 2008·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Olivier PrinceMichael J Mihatsch
May 12, 2010·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·H Tedesco SilvaY S Kim
May 31, 2011·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Antje HabichtAnke Schwarz
Jun 15, 2011·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·T BacheletJ-L Taupin
Aug 5, 2011·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·D C BrennanF S Shihab
Aug 6, 2011·The Journal of Surgical Research·Jennifer H KuoChristoph Troppmann
Dec 14, 2011·Clinical Journal of the American Society of Nephrology : CJASN·Joseph KahwajiAshley Vo
Feb 1, 2012·Transplantation·John R MontgomeryDorry L Segev
Jan 30, 2014·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·M HaasUNKNOWN Banff meeting report writing committee
Jul 30, 2014·Transplant International : Official Journal of the European Society for Organ Transplantation·Annelies E de WeerdMichiel G H Betjes

❮ Previous
Next ❯

Citations

Dec 17, 2015·Expert Opinion on Drug Safety·Pedro Ventura AguiarFritz Diekmann
Oct 28, 2016·Transplant International : Official Journal of the European Society for Organ Transplantation·Carlos CerveraFrederic Oppenheimer
Mar 30, 2017·Archives of Disease in Childhood·Michael A Cardis, Cynthia Marie Carver DeKlotz
Sep 11, 2018·Experimental and Clinical Transplantation : Official Journal of the Middle East Society for Organ Transplantation·Junji UchidaTatsuya Nakatani
Aug 29, 2019·Langenbeck's Archives of Surgery·Bernd Martin JänigenPrzemyslaw Pisarski
Aug 24, 2017·Clinical Transplantation·Gérôme BohelayUNKNOWN Skin and Organ Transplantation Group of the French Society of Dermatology
Sep 16, 2019·International Journal of Urology : Official Journal of the Japanese Urological Association·Junji UchidaTatsuya Nakatani

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.